Terms: = Lung cancer AND IDH2, P48735, 3418, ENSG00000182054, IDHM, mNADP-IDH, IDH, IDP, ICD-M AND Prognosis
12 results:
1. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract] [Full Text] [Related]
2. Identifying Acss1, Mtfp1 and Oxct1 as key regulators and promising biomarkers of sarcopenia in various models.
Cui H; Hu D; Liu Y; Zhao J
Gene; 2024 Feb; 896():148053. PubMed ID: 38042218
[TBL] [Abstract] [Full Text] [Related]
3. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
Zhao S; Li Y; Xu J; Shen L
Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
[TBL] [Abstract] [Full Text] [Related]
4. A Novel Prognostic Signature Revealed the Interaction of Immune Cells in Tumor Microenvironment Based on Single-Cell RNA Sequencing for lung Adenocarcinoma.
Jin X; Hu Z; Sui Q; Zhao M; Liang J; Liao Z; Zheng Y; Wang H; Shi Y
J Immunol Res; 2022; 2022():6555810. PubMed ID: 35812244
[TBL] [Abstract] [Full Text] [Related]
5. neoDL: a novel neoantigen intrinsic feature-based deep learning model identifies idh wild-type glioblastomas with the longest survival.
Sun T; He Y; Li W; Liu G; Li L; Wang L; Xiao Z; Han X; Wen H; Liu Y; Chen Y; Wang H; Li J; Fan Y; Zhang W; Zhang J
BMC Bioinformatics; 2021 Jul; 22(1):382. PubMed ID: 34301201
[TBL] [Abstract] [Full Text] [Related]
6. [Clinical analysis of 12 cases of acute myeloid leukemia complicated with synchronous primary solid tumor].
Mi RH; Dang HB; Chen L; Han YL; Wang MF; Zhang YL; Chen L; Li DB; Wei XD
Zhonghua Yi Xue Za Zhi; 2020 Nov; 100(42):3323-3327. PubMed ID: 33202495
[No Abstract] [Full Text] [Related]
7. Long noncoding RNA MALAT1 may be a prognostic biomarker in idh1/2 wild-type primary glioblastomas.
Argadal OG; Mutlu M; Ak Aksoy S; Kocaeli H; Tunca B; Civan MN; Egeli U; Cecener G; Bekar A; Taskapilioglu MO; Tekin C; Tezcan G; Tolunay S
Bosn J Basic Med Sci; 2020 Feb; 20(1):63-69. PubMed ID: 31479414
[TBL] [Abstract] [Full Text] [Related]
8. Anti-Apoptotic and Anti-Oxidant Proteins in Glioblastomas: Immunohistochemical Expression of Beclin and DJ-1 and Its Correlation with prognosis.
Guadagno E; Borrelli G; Pignatiello S; Donato A; Presta I; Arcidiacono B; Malara N; Solari D; Somma T; Cappabianca P; Donato G; Del Basso De Caro M
Int J Mol Sci; 2019 Aug; 20(16):. PubMed ID: 31434323
[TBL] [Abstract] [Full Text] [Related]
9. idh2 is a novel diagnostic and prognostic serum biomarker for non-small-cell lung cancer.
Li JJ; Li R; Wang W; Zhang B; Song X; Zhang C; Gao Y; Liao Q; He Y; You S; Tan Z; Luo X; Li Y; Tang M; Weng X; Yi W; Peng S; Liu S; Tan Y; Bode AM; Cao Y
Mol Oncol; 2018 May; 12(5):602-610. PubMed ID: 29465809
[TBL] [Abstract] [Full Text] [Related]
10. Expression of enzymes related to glucose metabolism in non-small cell lung cancer and prognosis.
Giatromanolaki A; Sivridis E; Arelaki S; Koukourakis MI
Exp Lung Res; 2017; 43(4-5):167-174. PubMed ID: 28644754
[TBL] [Abstract] [Full Text] [Related]
11. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
[TBL] [Abstract] [Full Text] [Related]
12. The CpG island methylator phenotype: what's in a name?
Hughes LA; Melotte V; de Schrijver J; de Maat M; Smit VT; Bovée JV; French PJ; van den Brandt PA; Schouten LJ; de Meyer T; van Criekinge W; Ahuja N; Herman JG; Weijenberg MP; van Engeland M
Cancer Res; 2013 Oct; 73(19):5858-68. PubMed ID: 23801749
[TBL] [Abstract] [Full Text] [Related]
